Luteolin Protects Pancreatic β Cells against Apoptosis through Regulation of Autophagy and ROS Clearance
暂无分享,去创建一个
Yu-ting Lu | Jingya Li | M. Han | Honghong Xu | Xinwen Zhang | Yunhua Tao | Chengqiu Dai | Bingqian Zhang
[1] C. Xiao,et al. The protection of luteolin against diabetic cardiomyopathy in rats is related to reversing JNK-suppressed autophagy. , 2023, Food & function.
[2] Xinchao Li,et al. New insights into the characteristics of DRAK2 and its role in apoptosis: From molecular mechanisms to clinically applied potential , 2022, Frontiers in Pharmacology.
[3] C. Gonçalves-de-Albuquerque,et al. Flavonols and Flavones as Potential anti-Inflammatory, Antioxidant, and Antibacterial Compounds , 2022, Oxidative medicine and cellular longevity.
[4] P. Plastina,et al. Aluminum(III), iron(III) and copper(II) complexes of luteolin: stability, antioxidant, and anti-inflammatory properties , 2021, Journal of Molecular Liquids.
[5] Yimin Yan,et al. Luteolin alleviates cognitive impairment in Alzheimer’s disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation , 2021, Acta Pharmacologica Sinica.
[6] E. Walker,et al. A Selective Look at Autophagy in Pancreatic β-Cells , 2021, Diabetes.
[7] P. Conti,et al. Powerful anti‐inflammatory action of luteolin: Potential increase with IL‐38 , 2021, BioFactors.
[8] Jingcheng Dong,et al. Luteolin inhibits autophagy in allergic asthma by activating PI3K/Akt/mTOR signaling and inhibiting Beclin-1-PI3KC3 complex. , 2021, International immunopharmacology.
[9] M. Ashrafizadeh,et al. Autophagy regulation using luteolin: new insight into its anti-tumor activity , 2020, Cancer Cell International.
[10] M. Rezaie,et al. Structure-Antioxidant Activity Relationships of Luteolin and Catechin. , 2020, Journal of food science.
[11] G. Liang,et al. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[12] F. Nan,et al. Sulfuretin protects hepatic cells through regulation of ROS levels and autophagic flux , 2018, Acta Pharmacologica Sinica.
[13] Dhiraj Kumar,et al. Can luteolin be a therapeutic molecule for both colon cancer and diabetes? , 2018, Briefings in functional genomics.
[14] S. Inzucchi,et al. Metformin: clinical use in type 2 diabetes , 2017, Diabetologia.
[15] B. Han,et al. Discovery of benzofuran-3(2H)-one derivatives as novel DRAK2 inhibitors that protect islet β-cells from apoptosis. , 2017, European journal of medicinal chemistry.
[16] Xiaodong Zheng,et al. Mulberry anthocyanin extract ameliorates insulin resistance by regulating PI3K/AKT pathway in HepG2 cells and db/db mice. , 2016, The Journal of nutritional biochemistry.
[17] S. Ray,et al. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo , 2016, Apoptosis.
[18] I. Sumara,et al. Insulin secretory granules control autophagy in pancreatic β cells , 2015, Science.
[19] N. Sarvetnick,et al. Inhibition of Autophagic Turnover in β-Cells by Fatty Acids and Glucose Leads to Apoptotic Cell Death* , 2014, The Journal of Biological Chemistry.
[20] Myung-Shik Lee. Role of islet β cell autophagy in the pathogenesis of diabetes , 2014, Trends in Endocrinology & Metabolism.
[21] A. Kimchi,et al. DAPK2 is a novel regulator of mTORC1 activity and autophagy , 2014, Cell Death and Differentiation.
[22] P. Herdewijn,et al. Discovery of dual death-associated protein related apoptosis inducing protein kinase 1 and 2 inhibitors by a scaffold hopping approach. , 2014, Journal of medicinal chemistry.
[23] A. Kimchi,et al. The DAP-kinase interactome , 2014, Apoptosis.
[24] A. Kimchi,et al. DAP-kinase and autophagy , 2014, Apoptosis.
[25] S. Yagihashi,et al. Exendin-4 improves β-cell function in autophagy-deficient β-cells. , 2013, Endocrinology.
[26] Xiaoqun Duan,et al. Anti-diabetic effects of puerarin, isolated from Pueraria lobata (Willd.), on streptozotocin-diabetogenic mice through promoting insulin expression and ameliorating metabolic function. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[27] S. Oh,et al. Autophagy deficiency in beta cells leads to compromised unfolded protein response and progression from obesity to diabetes in mice , 2012, Diabetologia.
[28] A. Kimchi,et al. PKD is a kinase of Vps34 that mediates ROS-induced autophagy downstream of DAPk , 2011, Cell Death and Differentiation.
[29] O. Shirihai,et al. Fatty Acids Suppress Autophagic Turnover in β-Cells* , 2011, The Journal of Biological Chemistry.
[30] W. Han,et al. Deficiency in RNA editing enzyme ADAR2 impairs regulated exocytosis , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] M. Düfer,et al. Oxidative stress and beta-cell dysfunction , 2010, Pflügers Archiv - European Journal of Physiology.
[32] M. Eisenstein,et al. Phosphorylation of Beclin 1 by DAP-kinase promotes autophagy by weakening its interactions with Bcl-2 and Bcl-XL , 2009, Autophagy.
[33] B. Han,et al. Drak2 Is Upstream of p70S6 Kinase: Its Implication in Cytokine-Induced Islet Apoptosis, Diabetes, and Islet Transplantation1 , 2009, The Journal of Immunology.
[34] Miriam Eisenstein,et al. DAP‐kinase‐mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl‐XL and induction of autophagy , 2009, EMBO reports.
[35] Hongyu Luo,et al. Drak2 overexpression results in increased β‐cell apoptosis after free fatty acid stimulation , 2008, Journal of cellular biochemistry.
[36] Kun Wook Chung,et al. Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia. , 2008, Cell metabolism.
[37] Masaaki Komatsu,et al. Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. , 2008, Cell metabolism.
[38] R. Robertson,et al. Diabetes, glucose toxicity, and oxidative stress: A case of double jeopardy for the pancreatic islet beta cell. , 2006, Free radical biology & medicine.
[39] R. Robertson,et al. β-Cell Glucose Toxicity, Lipotoxicity, and Chronic Oxidative Stress in Type 2 Diabetes , 2004 .
[40] J. Richardson,et al. Essential Role of STAT3 in Body Weight and Glucose Homeostasis , 2004, Molecular and Cellular Biology.
[41] Robert A. Rizza,et al. β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.
[42] A. Kimchi,et al. Death-Associated Protein Kinase-Related Protein 1, a Novel Serine/Threonine Kinase Involved in Apoptosis , 2000, Molecular and Cellular Biology.
[43] S. Akira,et al. Death-associated protein kinase 2 is a new calcium/calmodulin-dependent protein kinase that signals apoptosis through its catalytic activity , 1999, Oncogene.
[44] S. Akira,et al. DRAKs, Novel Serine/Threonine Kinases Related to Death-associated Protein Kinase That Trigger Apoptosis* , 1998, The Journal of Biological Chemistry.
[45] Shizuo Akira,et al. ZIP Kinase, a Novel Serine/Threonine Kinase Which Mediates Apoptosis , 1998, Molecular and Cellular Biology.
[46] J. Levy,et al. U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease , 1995, Diabetes.
[47] Yong Li,et al. Quercetin and quercitrin protect against cytokine‑induced injuries in RINm5F β-cells via the mitochondrial pathway and NF-κB signaling. , 2013, International journal of molecular medicine.
[48] R. Robertson,et al. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. , 2004, Diabetes.
[49] Robert A Rizza,et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. , 2003, Diabetes.
[50] A. Kimchi,et al. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. , 1995, Genes & development.